Á lódáil...
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
BACKGROUND: Combined inhibition of BRAF/MEK is an established therapy for melanoma. In addition to its canonical mode of action, effects of BRAF/MEK inhibitors on antitumor immune responses are emerging. Thus, we investigated the effect of these on adaptive immune responses. PATIENTS, METHODS AND RE...
Na minha lista:
| Foilsithe in: | Cancer Immunol Immunother |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Springer Berlin Heidelberg
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8139931/ https://ncbi.nlm.nih.gov/pubmed/33275172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02804-4 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|